Distributive shock, also known as vasodilatory shock, is one of the four broad classifications of disorders that cause inadequate tissue perfusion. Systemic vasodilation leads to decreased blood flow to the brain, heart, and kidneys causing damage to vital organs. Distributive shock also leads to leakage of fluid from capillaries into the surrounding tissues, further complicating the clinical picture. Due to the complexities of this disease, the causes and treatments for distributive shock are multimodal.
The most common causes of distributive shock in the emergency department are sepsis and anaphylaxis. In cases of trauma, neurogenic shock should also be on the differential. Other less common causes of distributive shock include adrenal insufficiency and capillary leak syndrome. Drug overdose or toxicity should always be considered, particularly potent vasodilators such as calcium channel blockers and hydralazine.
Distributive shock as a result of sepsis occurs due to a dysregulated immune response to infection that leads to systemic cytokine release and resultant vasodilation and fluid leak from capillaries. These inflammatory cytokines can also cause some cardiac dysfunction, called septic cardiomyopathy, which can contribute to the shock state.
In anaphylaxis, the patient typically has a history of previous exposure to an antigen, although this is not required, with resulting IgE formation to that antigen. These IgE molecules then attach to the surface of mast cells in the tissues and basophils in blood. Consequent exposure to the same antigen results in the IgE-mediated release of histamine from mast cells and basophils, leading to systemic vasodilation and capillary fluid leak.
Toxic shock syndrome should be considered in distributive shock. This disease is caused by Staphylococcus aureus and group A streptococci exotoxins that stimulate systemic cytokine release with resulting vasodilation and capillary leak. Historically, this is associated with both vaginal and nasal tampon use.
Neurogenic shock classically occurs in cases of trauma involving the cervical spinal cord. The sympathetic nervous system is damaged resulting in a decreased adrenergic input to the blood vessels and heart, causing vasodilation with resultant hypotension and a paradoxical bradycardia.
The distributive shock from adrenal insufficiency occurs due to decreased alpha-1 receptor expression on arterioles secondary to cortisol deficiency, which results in vasodilation. This is seen in patients on chronic steroids that are stopped suddenly.
Capillary leak syndrome, while rare, should be considered in the edematous patient with distributive shock. It occurs due to low blood albumin. Decreased oncotic pressure leads to fluid loss from the blood into the interstitium.
Septic shock is the most common cause of distributive shock seen in the emergency department. The number of patients admitted with severe sepsis now approaches one million per year with mortality rates extending 50%. It’s crucial to note that nearly 50% of septic patients that present with some degree of end-organ damage will have cryptic shock, meaning they have inadequate tissue perfusion despite a normal blood pressure reading. Anaphylaxis, likely the second leading etiology of distributive shock, can occur at any age regardless of prior history. Nut allergy and history of asthma have been identified as independent predictors of mortality in patients with anaphylaxis, and great care should be taken when monitoring this subset of patients.
In most cases, inflammatory mediators play a major role in the development of distributive shock. Inflammatory cytokines released in both sepsis and toxic shock syndrome induce systemic vasodilation and capillary leak, as well as cardiomyopathy. The systemic release of histamine in anaphylaxis results in similar effects.
Interactions between catecholamines and adrenergic receptors in the blood vessels are crucial in other causes of distributive shock. Both norepinephrine and epinephrine stimulate alpha-1 receptors on arterioles to cause vasoconstriction and regulate blood pressure. In the case of neurogenic shock, the sympathetic nervous system is compromised, leading to reduced catecholamine delivery to these receptors. Cortisol is a key regulator of the expression of alpha-1 receptors on the arteriolar surface, but this becomes compromised in patients with adrenal insufficiency.
In effect, the factors leading to vasodilation and shock are multimodal and complex. This necessitates a careful history and physical examination to elucidate the underlying cause and a multi-system approach to treatment.
If possible, a careful and directed history should be taken directly from the patient. Often this is not possible, and information should be collected from the emergency management service, family members, or other witnesses of the inciting event. Symptoms of infection, like shortness of breath, cough, fever, chills, nausea, vomiting, abdominal pain, and dysuria, as well as an immunocompromised status and recent hospitalizations, should be noted as this information may point to sepsis. Additionally, identifying known allergies and a history of anaphylaxis as well as possible.
Exposures to known allergens can aid identification of the cause of the patient’s presentation. Review the patient’s medications, particularly steroids and anti-hypertensives, and illicit drug use to determine if overdose or intoxication could be contributing to the clinical picture.
While the physical exam is unreliable in determining the source of shock, some findings can be suggestive of underlying etiology. Warm extremities can point to vasodilation as the cause of shock. A careful skin exam should be completed to identify a cutaneous source of infection such as cellulitis, ulcers, or abscess. Urticaria strongly suggests anaphylaxis.
In undifferentiated patients that present to the emergency department with shock, the exact etiology is often unclear. As always, the evaluation should begin with a primary survey evaluating the airway, breathing, and circulation as well as establishing adequate intravenous (IV) access and hemodynamic monitoring. The patient should be fully exposed and a rapid head to toe examination performed. While definitive airway management is needed in many of these patients, efforts should be made to optimize hemodynamics before intubation to avoid precipitating cardiac arrest. ECG should be obtained rapidly to identify arrhythmias or ischemia which can mimic the clinical picture of distributive shock. Obtain a portable chest x-ray to identify pneumonia, pulmonary edema, or pneumothorax. Bedside ultrasound utilizing the RUSH (Rapid Ultrasound for Shock) exam allows rapid evaluation of global cardiac function and fluid status and helps to identify pericardial tamponade, pulmonary edema, pneumothorax, or occult intra-abdominal hemorrhage. Collect a full spectrum of labs, including lactate, blood and urine cultures, blood gas, and a pregnancy test in females of reproductive age.
Regardless of the type of shock, the majority of patients will tolerate and benefit from an initial fluid bolus of 250-500 mL. Patients with distributive shock are significantly more likely to require vasopressor support. The ultimate goal is to achieve adequate tissue perfusion utilizing fluid resuscitation and vasopressors. This can be achieved by targeting a mean arterial pressure of greater than 65 mmHg, which is the approximate critical perfusion pressure for both the heart and kidneys. Adequacy of tissue perfusion can be monitored with multiple modalities, including physical exam, Scv02 greater than or equal to 70%, and laboratory parameters including lactate and base deficit. The pressor choice will vary depending on the suspected etiology of distributive shock.
In septic shock, the initial pressor of choice is norepinephrine (2 mcg/min to 20 mcg/min), as this offers both alpha-1 and beta-1 stimulation, which will increase peripheral vasoconstriction without significantly compromising cardiac output. Vasopressin (0.03 U/min to 0.04 U/min) is a second-line agent which acts primarily as a vasoconstrictor by binding to V1 receptors. Attention should also be given to aggressive fluid resuscitation (Per the surviving sepsis campaign, 30 mL/kg in the first 3 hours), early antibiotic administration, and source control.
For cases of anaphylactic shock, epinephrine is the pressor of choice, as it offers alpha-1 and beta-1 stimulation similar to norepinephrine but also provides beta-2 stimulation, which stimulates bronchodilation and stabilization of mast cells and basophils. Adjunct interventions will include both H1 and H2 antihistamines, steroids, albuterol, fluids, and potentially glucagon for those using beta-blockers.
The shock that is unresponsive to both fluids and vasopressors may indicate adrenal insufficiency. In such cases, steroids can be given to the increased arteriolar expression of alpha-1 receptors. Hydrocortisone 100 mg is the typical treatment.
In cases where vasopressor drips are not immediately available, and the patient has critically low perfusion pressure (particularly MAP less than 50 mmHg, the critical perfusion pressure to the brain), push dose vasopressors can be utilized. Epinephrine and phenylephrine are common agents of choice for this purpose.
The approach to the distributive shock patient begins with attaining adequate perfusion pressure to vital organs with fluids and vasopressors. Definitive airway management is often necessary but should not precede some degree of hemodynamic stabilization. Rapid identification of the underlying etiology with appropriate treatment is crucial to resolving the cause of pathologic vasodilation and ultimate patient recovery.
Distributive shock is best managed by a multidisciplinary team that includes ICU nurses. The key is to maintain a perfusion pressure of at least 65 mmHg. Fluids are usually the first choice treatment followed by use of vasopressors. The primary cause of distributive shock must be identfied and treated if the outcome is to be improved.
Patients who do respond to a fluid challenge and have no organ failure have good outcomes. Patients with multiple organ dysfunction and the need for high doses of vasopressors usually have a poor outcome. (Level V)
|||Asmundsson ASE,Bjorklund AR,Fisher GA, Diagnosis of Systemic Capillary Leak Syndrome in a Young Child Treated with Intravenous Immunoglobulin in the Acute Phase. Journal of pediatric intensive care. 2018 Jun; [PubMed PMID: 31073478]|
|||Rahulkumar HH,Bhavin PR,Shreyas KP,Krunalkumar HP,Atulkumar S,Bansari C, Utility of Point-of-Care Ultrasound in Differentiating Causes of Shock in Resource-Limited Setup. Journal of emergencies, trauma, and shock. 2019 Jan-Mar; [PubMed PMID: 31057278]|
|||Berg DD,Bohula EA,van Diepen S,Katz JN,Alviar CL,Baird-Zars VM,Barnett CF,Barsness GW,Burke JA,Cremer PC,Cruz J,Daniels LB,DeFilippis AP,Haleem A,Hollenberg SM,Horowitz JM,Keller N,Kontos MC,Lawler PR,Menon V,Metkus TS,Ng J,Orgel R,Overgaard CB,Park JG,Phreaner N,Roswell RO,Schulman SP,Jeffrey Snell R,Solomon MA,Ternus B,Tymchak W,Vikram F,Morrow DA, Epidemiology of Shock in Contemporary Cardiac Intensive Care Units. Circulation. Cardiovascular quality and outcomes. 2019 Mar; [PubMed PMID: 30879324]|
|||Standl T,Annecke T,Cascorbi I,Heller AR,Sabashnikov A,Teske W, The Nomenclature, Definition and Distinction of Types of Shock. Deutsches Arzteblatt international. 2018 Nov 9; [PubMed PMID: 30573009]|
|||Gabbay U,Carmi D,Birk E,Dagan D,Shatz A,Kidron D, The Sudden Infant Death Syndrome mechanism of death may be a non-septic hyper-dynamic shock. Medical hypotheses. 2019 Jan; [PubMed PMID: 30593418]|
|||Smith MD,Maani CV, Norepinephrine 2019 Jan; [PubMed PMID: 30725944]|
|||Casey JD,Brown RM,Semler MW, Resuscitation fluids. Current opinion in critical care. 2018 Dec; [PubMed PMID: 30247219]|
|||Mendelson J, Emergency Department Management of Pediatric Shock. Emergency medicine clinics of North America. 2018 May; [PubMed PMID: 29622332]|
|||Silva J,Gonçalves L,Sousa PP, Fluid therapy and shock: an integrative literature review. British journal of nursing (Mark Allen Publishing). 2018 Apr 26; [PubMed PMID: 29683753]|
|||Hooper N,Armstrong TJ, Hemorrhagic Shock 2019 Jan; [PubMed PMID: 29262047]|
|||Vincent JL,Leone M, Optimum treatment of vasopressor-dependent distributive shock. Expert review of anti-infective therapy. 2017 Jan; [PubMed PMID: 27774825]|
|||Ince C, The rationale for microcirculatory guided fluid therapy. Current opinion in critical care. 2014 Jun; [PubMed PMID: 24758985]|
|||Lodha R,Kapoor V, Peripheral circulatory failure. Indian journal of pediatrics. 2003 Feb; [PubMed PMID: 12661813]|
|||Roumpf SK,Hunter BR, Does the Addition of Vasopressin to Catecholamine Vasopressors Affect Outcomes in Patients With Distributive Shock? Annals of emergency medicine. 2018 Nov 13; [PubMed PMID: 30446352]|
|||Nedel WL,Rech TH,Ribeiro RA,Pellegrini JAS,Moraes RB, Renal Outcomes of Vasopressin and Its Analogs in Distributive Shock: A Systematic Review and Meta-Analysis of Randomized Trials. Critical care medicine. 2019 Jan; [PubMed PMID: 30303842]|